Literature DB >> 33262527

FAM122A is required for hematopoietic stem cell function.

Man-Hua Liu1, Xiao-Cui Zhang1, Jing Chen1, Yun-Sheng Yang1, Yin-Qi Wang1, Jun-Ke Zheng1, Guo-Qiang Chen2, Ying Huang3.   

Abstract

Entities:  

Year:  2020        PMID： 33262527      PMCID： PMC8257486          DOI： 10.1038/s41375-020-01099-9

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

Review 1.  Activation and signaling of the p38 MAP kinase pathway.

Authors:  Tyler Zarubin; Jiahuai Han
Journal:  Cell Res       Date:  2005-01       Impact factor: 25.617

2.  SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells.

Authors:  Mark J Kiel; Omer H Yilmaz; Toshihide Iwashita; Osman H Yilmaz; Cox Terhorst; Sean J Morrison
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

3.  HemaExplorer: a Web server for easy and fast visualization of gene expression in normal and malignant hematopoiesis.

Authors:  Frederik Otzen Bagger; Nicolas Rapin; Kim Theilgaard-Mönch; Bogumil Kaczkowski; Johan Jendholm; Ole Winther; Bo Porse
Journal:  Blood       Date:  2012-06-28       Impact factor: 22.113

4.  Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells.

Authors:  Keisuke Ito; Atsushi Hirao; Fumio Arai; Keiyo Takubo; Sahoko Matsuoka; Kana Miyamoto; Masako Ohmura; Kazuhito Naka; Kentaro Hosokawa; Yasuo Ikeda; Toshio Suda
Journal:  Nat Med       Date:  2006-03-26       Impact factor: 53.440

5.  Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells.

Authors:  J L Christensen; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

6.  Hematopoietic stem cell quiescence and function are controlled by the CYLD-TRAF2-p38MAPK pathway.

Authors:  Melania Tesio; Yilang Tang; Katja Müdder; Massimo Saini; Lisa von Paleske; Elizabeth Macintyre; Manolis Pasparakis; Ari Waisman; Andreas Trumpp
Journal:  J Exp Med       Date:  2015-03-30       Impact factor: 14.307

7.  FAM122A, a new endogenous inhibitor of protein phosphatase 2A.

Authors:  Li Fan; Man-Hua Liu; Meng Guo; Chuan-Xi Hu; Zhao-Wen Yan; Jing Chen; Guo-Qiang Chen; Ying Huang
Journal:  Oncotarget       Date:  2016-09-27

Review 8.  Stem cells: past, present, and future.

Authors:  Wojciech Zakrzewski; Maciej Dobrzyński; Maria Szymonowicz; Zbigniew Rybak
Journal:  Stem Cell Res Ther       Date:  2019-02-26       Impact factor: 6.832

9.  FAM122A promotes acute myeloid leukemia cell growth through inhibiting PP2A activity and sustaining MYC expression.

Authors:  Man-Hua Liu; Jing Chen; Yun-Sheng Yang; Yin-Qi Wang; Guo-Qiang Chen; Yu Zhang; Ying Huang
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941

Review 10.  'Acute myeloid leukemia: a comprehensive review and 2016 update'.

Authors:  I De Kouchkovsky; M Abdul-Hay
Journal:  Blood Cancer J       Date:  2016-07-01       Impact factor: 11.037
View more
  1 in total

1.  ANP32B-mediated repression of p53 contributes to maintenance of normal and CML stem cells.

Authors:  Shuo Yang; Xiao-Na Zhu; Hui-Lin Zhang; Qian Yang; Yu-Sheng Wei; Di Zhu; Meng-Di Liu; Shao-Ming Shen; Li Xia; Ping He; Meng-Kai Ge; Yi-Lian Pan; Meng Zhao; Ying-Li Wu; Jun-Ke Zheng; Guo-Qiang Chen; Yun Yu
Journal:  Blood       Date:  2021-12-16       Impact factor: 22.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.